← FDA DRUG APPROVALS

FDA ANDA · ANDA090697

RAMIPRIL

Sponsor: ZYDUS PHARMS USA INC

APPLICATION
ANDA090697
TYPE
ANDA
ORIGINAL APPROVAL
2009-09-24
LATEST ACTION
2014-12-06
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

RAMIPRILDiscontinued
RAMIPRIL 5MG · TABLET · ORAL
RAMIPRILDiscontinued
RAMIPRIL 1.25MG · TABLET · ORAL
RAMIPRILDiscontinued
RAMIPRIL 10MG · TABLET · ORAL
RAMIPRILDiscontinued
RAMIPRIL 2.5MG · TABLET · ORAL

Approval history

2014-12-06Labeling · Supplement 2AP
2014-12-06Labeling · Supplement 3AP
2011-07-22Labeling · Supplement 1AP
2009-09-24OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →